DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ASTODRIMER SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ASTODRIMER SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
8Q3B8SV59L
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
STI-6643
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
STI-6643
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-9977
1
Small molecule
Investigational
Unknown
Unknown
Cardiovascular Diseases; Heart Failure; Kidney Diseases
Mineralocorticoid receptor modulator
AZD-9977
×
Maximum Phase:
1
First Approval:
None
UNII:
6C9UKZ0CYE
Molecule Type:
Small molecule
Molecular Formula:
C20H18FN3O5
Molecular Weight:
399.38
AlogP:
1.7
PSA:
96.97
HBD:
2.0
HBA:
#RotB:
3.0
Source:
LY-2780301
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasm Metastasis
Ribosomal protein S6 kinase (P70S6K) inhibitor
LY-2780301
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DI-LEU16-IL2
1
Unknown
Investigational
Unknown
Unknown
Lymphoma, Follicular
Unknown
DI-LEU16-IL2
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARC1905
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ARC1905
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ASTX-660
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Lymphoma
Unknown
ASTX-660
×
Maximum Phase:
1
First Approval:
None
UNII:
2LHZ9ZC3YO
Molecule Type:
Small molecule
Molecular Formula:
C30H42FN5O3
Molecular Weight:
539.7
AlogP:
2.31
PSA:
81.17
HBD:
2.0
HBA:
#RotB:
7.0
Source:
SONIFILAN
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
SONIFILAN
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DANICAMTIV
1
Small molecule
Investigational
Unknown
Unknown
Cardiomyopathy, Dilated
Cardiac myosin activator
DANICAMTIV
×
Maximum Phase:
1
First Approval:
None
UNII:
7B2CS922HI
Molecule Type:
Small molecule
Molecular Formula:
C16H20F3N5O4S
Molecular Weight:
435.43
AlogP:
2.75
PSA:
110.33
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TRICIRIBINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TRICIRIBINE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ALDOSTERONE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ALDOSTERONE
×
Maximum Phase:
1
First Approval:
None
UNII:
4964P6T9RB
Molecule Type:
Small molecule
Molecular Formula:
C21H28O5
Molecular Weight:
360.45
AlogP:
1.85
PSA:
91.67
HBD:
2.0
HBA:
#RotB:
3.0
Source:
SNDX-5613
1
Small molecule
Investigational
Unknown
Unknown
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Menin/Histone-lysine N-methyltransferase MLL inhibitor
SNDX-5613
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C76H106F2N12O20S2
Molecular Weight:
1609.88
AlogP:
4.68
PSA:
107.97
HBD:
1.0
HBA:
#RotB:
11.0
Source:
CORESEVIN M
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
CORESEVIN M
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MILCICLIB MALEATE
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
MILCICLIB MALEATE
×
Maximum Phase:
1
First Approval:
None
UNII:
82W826FL6S
Molecule Type:
Small molecule
Molecular Formula:
C29H36N8O5
Molecular Weight:
576.66
AlogP:
2.57
PSA:
91.21
HBD:
2.0
HBA:
#RotB:
4.0
Source:
BMS-936559
1
Unknown
Investigational
Unknown
Unknown
HIV Infections
Unknown
BMS-936559
×
Maximum Phase:
1
First Approval:
None
UNII:
TLZ6R6973Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SB-743921
1
Small molecule
Investigational
Unknown
Unknown
Hodgkin Disease; Lymphoma, Non-Hodgkin; Neoplasms
Unknown
SB-743921
×
Maximum Phase:
1
First Approval:
None
UNII:
24DSZ1VN92
Molecule Type:
Small molecule
Molecular Formula:
C31H33ClN2O3
Molecular Weight:
517.07
AlogP:
6.53
PSA:
76.54
HBD:
1.0
HBA:
#RotB:
9.0
Source:
FIBROBLAST GROWTH FACTOR-1
1
Unknown
Investigational
Unknown
Unknown
Diabetic Foot
Unknown
FIBROBLAST GROWTH FACTOR-1
×
Maximum Phase:
1
First Approval:
None
UNII:
G53298VN9Y
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CAL-263
1
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
PI3-kinase p110-delta subunit inhibitor
CAL-263
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ULILEDLIMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
ULILEDLIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
N-ACETYLGLUCOSAMINE
1
Small molecule
Investigational
Unknown
Unknown
Malnutrition
Unknown
N-ACETYLGLUCOSAMINE
×
Maximum Phase:
1
First Approval:
None
UNII:
8P59336F68
Molecule Type:
Small molecule
Molecular Formula:
C8H15NO6
Molecular Weight:
221.21
AlogP:
-3.08
PSA:
119.25
HBD:
5.0
HBA:
#RotB:
2.0
Source:
DOTAMTATE
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
DOTAMTATE
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1637.88
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
RAD-140
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Unknown
RAD-140
×
Maximum Phase:
1
First Approval:
None
UNII:
4O87Q44KNC
Molecule Type:
Small molecule
Molecular Formula:
C20H16ClN5O2
Molecular Weight:
393.83
AlogP:
3.98
PSA:
118.76
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TC-2216
1
Small molecule
Investigational
Unknown
Unknown
Anxiety; Depressive Disorder
Neuronal acetylcholine receptor; alpha4/beta2 antagonist
TC-2216
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C12H17N3
Molecular Weight:
203.29
AlogP:
1.41
PSA:
28.16
HBD:
1.0
HBA:
#RotB:
1.0
Source:
SOR-C13
1
Protein
Investigational
Unknown
Unknown
Neoplasms
Unknown
SOR-C13
×
Maximum Phase:
1
First Approval:
None
UNII:
C79B5A73C4
Molecule Type:
Protein
Molecular Formula:
C72H116N20O19
Molecular Weight:
1565.84
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
MIK-BETA-1
1
Antibody
Investigational
Unknown
Unknown
Leukemia
Interleukin-2 receptor beta chain inhibitor
MIK-BETA-1
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VAPALIXIMAB
1
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
VAPALIXIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
M1EGR25LBB
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EMB-01
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
EMB-01
×
Maximum Phase:
1
First Approval:
None
UNII:
G86X5QQ7M5
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BUDIGALIMAB
1
Antibody
Investigational
Unknown
Unknown
Breast Neoplasms; Colorectal Neoplasms; Head and Neck Neoplasms; HIV Infections; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma
Programmed cell death protein 1 inhibitor
BUDIGALIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
6VDO4TY3OO
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
R(+)XK469
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Neuroblastoma
Unknown
R(+)XK469
×
Maximum Phase:
1
First Approval:
None
UNII:
8VSJ573G09
Molecule Type:
Small molecule
Molecular Formula:
C17H13ClN2O4
Molecular Weight:
344.75
AlogP:
3.93
PSA:
81.54
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RXDX-103
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cell division cycle 7-related protein kinase inhibitor
RXDX-103
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
POSIPHEN
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
POSIPHEN
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZADIRACHTA INDICA
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AZADIRACHTA INDICA
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
SAR-441236
1
Unknown
Investigational
Unknown
Unknown
HIV Infections
Unknown
SAR-441236
×
Maximum Phase:
1
First Approval:
None
UNII:
XKF7EDC32B
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD-6918
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Neurotrophic tyrosine kinase receptor inhibitor
AZD-6918
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RGB-286638
1
Small molecule
Investigational
Unknown
Unknown
Hematologic Neoplasms
Cyclin-dependent kinase 1 inhibitor
RGB-286638
×
Maximum Phase:
1
First Approval:
None
UNII:
1GAJ98SC2X
Molecule Type:
Small molecule
Molecular Formula:
C29H35N7O4
Molecular Weight:
545.64
AlogP:
2.42
PSA:
115.06
HBD:
3.0
HBA:
#RotB:
8.0
Source:
1
2
…
119
120
121
122
123
124
125
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA